Owlet (OWLT) Liabilities and Shareholders Equity (2020 - 2026)
Owlet (OWLT) posted quarterly Liabilities and Shareholders Equity of $86.8 million for Q1 2026, up 68.8% year-over-year from $51.4 million in Q1 2025, and up 1.31% quarter-over-quarter from $85.6 million in Q4 2025.
Owlet (OWLT) Liabilities and Shareholders Equity (2020 - 2026) Analysis & Trends
Owlet (OWLT) has reported Liabilities and Shareholders Equity for 7 consecutive years, with $86.8 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Liabilities and Shareholders Equity rose 68.8% year-over-year to $86.8 million; the TTM figure through Mar 2026 stood at $310.8 million (up 53.15% YoY), while the FY2025 annual figure was $85.6 million, up 72.94% from the prior year.
- Liabilities and Shareholders Equity rose to $86.8 million in Q1 2026 per OWLT's latest filing, from $85.6 million in the prior quarter.
- Across five years, Liabilities and Shareholders Equity topped out at $124.1 million in Q1 2022 and bottomed at $42.3 million in Q3 2023.
- Historically, Liabilities and Shareholders Equity has averaged $66.6 million across 5 years, with a median of $58.1 million in 2022.
- Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity plunged 58.51% — and 2025, when it soared 72.94%.
- Owlet's Liabilities and Shareholders Equity stood at $58.1 million in 2022, then fell by 24.06% to $44.1 million in 2023, then climbed by 12.22% to $49.5 million in 2024, then jumped by 72.94% to $85.6 million in 2025, then climbed by 1.31% to $86.8 million in 2026.
- Business Quant data shows OWLT's Liabilities and Shareholders Equity at $86.8 million in Q1 2026, $85.6 million in Q4 2025, and $74.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn | 109.22 Bn |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn | 47.93 Bn |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn | 93.03 Bn |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn | 45.22 Bn |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | 13.87 Bn |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn | 6.46 Bn |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn | 37.25 Bn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 31.04 Bn |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn | 10.74 Bn |
| 10 | Owlet | 161.25 Mn | 124.70 Mn | 21.82 Mn | 93.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 93.57 Mn |
| Mar 31, 2026 | 86.76 Mn |
| Dec 31, 2025 | 85.63 Mn |
| Sep 30, 2025 | 74.87 Mn |
| Jun 30, 2025 | 63.54 Mn |
| Mar 31, 2025 | 51.40 Mn |
| Dec 31, 2024 | 49.52 Mn |
| Sep 30, 2024 | 56.13 Mn |
| Jun 30, 2024 | 45.90 Mn |
| Mar 31, 2024 | 43.83 Mn |
| Dec 31, 2023 | 44.12 Mn |
| Sep 30, 2023 | 42.29 Mn |
| Jun 30, 2023 | 57.26 Mn |
| Mar 31, 2023 | 65.93 Mn |
| Dec 31, 2022 | 58.10 Mn |
| Sep 30, 2022 | 80.68 Mn |
| Jun 30, 2022 | 101.88 Mn |
| Mar 31, 2022 | 124.12 Mn |
| Dec 31, 2021 | 140.05 Mn |
| Sep 30, 2021 | 160.28 Mn |